Loading chat...
IN HB1228
Bill
Status
2/3/2016
Primary Sponsor
Lloyd Arnold
Click for details
AI Summary
HB 1228 Summary
-
State seed commissioner may adopt rules to implement industrial hemp laws after securing necessary federal permissions, waivers, or legal status from the Drug Enforcement Agency or other appropriate federal agencies.
-
State encourages Indiana University School of Medicine and other state educational institutions to conduct physician-led research and clinical studies on cannabidiol oil (CBD) for treating intractable epilepsy.
-
Individuals with intractable seizure disorders may possess and use CBD oil (containing no more than 0.3% THC and at least 15 times more cannabidiol than THC by weight) without criminal penalties if they have a written physician recommendation and the product meets labeling and third-party laboratory verification requirements.
-
Physicians who issue written recommendations for CBD in treatment of intractable epilepsy receive immunity from civil, criminal, and administrative liability.
-
Effective date: July 1, 2016.
Legislative Description
Hemp. Allows the state seed commissioner to adopt rules ti implement laws concerning industrial hemp. Encourages Indiana University School of Medicine and other state educational institutions to research the use of cannabidiol oil (CBD) from a hemp plant in the treatment of intractable epilepsy. Provides that an individual who possesses or uses CBD from a hemp plant for the treatment of intractable epilepsy is not subject to criminal penalties for the possession or use of the CBD if certain conditions are met. Provides civil, criminal, and administrative immunity for a physician who recommends, dispenses, possesses, or administers CBD in the
Last Action
Senator Head removed as second sponsor
2/16/2016